Clinical Trial Update: Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating temozolomide as maintenance therapy after induction chemotherapy in extensive-stage small cell lung cancer. Sponsor: Ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Extensive-stage Small Cell Lung Cancer | Phase 2, Phase 3 | Status: UNKNOWN